China SXT Pharmaceuticals, Inc. (SXTC) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

Compression note: triangle compression is around 68%, so resolution moves may become sharper as the structure tightens.

📊 Technical Summary

The latest close for China SXT Pharmaceuticals, Inc. (SXTC) came in at 2.06 (+0.49%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +14.44%, with price is trading in the lower part of its roughly 52-week range (1.30–351.00), while ATR14 volatility is elevated at roughly 6.92% of price. RSI(14) is 34.8, reflecting a defensive momentum profile with buyers still struggling to regain control. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Nearby upside pressure sits around 4.47. A decisive move through that level would improve the short-term picture. Fundamentals snapshot: Revenue: 829,490 · Net income: -802,568 · EPS (basic): -0.25. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more